Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Speedel Begins Pivotal Trial Of SPP301 In Diabetic Nephropathy

July 8, 2005

By Jennifer Boggs

Sirna Adding $28M To Fund RNAi-Based Products Trials

July 7, 2005

By Jennifer Boggs

Sirna Adding $28M To Fund RNAi-Based Products Trials

July 7, 2005

By Jennifer Boggs

Tioga Formed To Develop Merck KGaA's Asimadoline

July 6, 2005

By Jennifer Boggs

Tioga Formed To Develop Merck KGaA's Asimadoline

July 6, 2005

By Jennifer Boggs

Penwest's PW2101 Receives Thumbs Down; Drug Shelved

July 1, 2005

By Jennifer Boggs

Penwest's PW2101 Receives Thumbs Down; Drug Shelved

July 1, 2005

By Jennifer Boggs

CV Therapeutics Raising $288M Via Stock, Notes

June 30, 2005

By Jennifer Boggs

CV Therapeutics Raising $288M Via Stock, Notes

June 30, 2005

By Jennifer Boggs

Cougar Adds Seocalcitol, Fattens Oncology Pipeline

June 29, 2005

By Jennifer Boggs

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...